Literature DB >> 11859009

Syntheses and binding affinities of 6-nitroquipazine analogues for serotonin transporter. Part 2: 4-substituted 6-nitroquipazines.

Byoung Se Lee1, Soyoung Chu, Bon-Su Lee, Dae Yoon Chi, Yun Seon Song, Changbae Jin.   

Abstract

Eleven 4-substituted derivatives of 6-nitroquipazine were synthesized and evaluated for their abilities to displace [3H]citalopram binding to the rat cortical synaptic membranes. Among them, 4-chloro-6-nitroquipazine was shown to possess the highest binding affinity (K(i=)0.03 nM) which was approximately 6 times higher than that of 6-nitroquipazine (K(i)=0.17 nM) itself. In this paper, we describe the syntheses of 4-substituted 6-nitroquipazine derivatives, the results of corresponding biological evaluation and the SAR study.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11859009     DOI: 10.1016/s0960-894x(02)00028-8

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  3 in total

1.  Synthesis, in vitro binding studies and docking of long-chain arylpiperazine nitroquipazine analogues, as potential serotonin transporter inhibitors.

Authors:  Małgorzata Jarończyk; Karol Wołosewicz; Mari Gabrielsen; Gabriel Nowak; Irina Kufareva; Aleksander P Mazurek; Aina W Ravna; Ruben Abagyan; Andrzej J Bojarski; Ingebrigt Sylte; Zdzisław Chilmonczyk
Journal:  Eur J Med Chem       Date:  2012-01-15       Impact factor: 6.514

2.  Studies of one-pot double couplings on dibromoquinolines.

Authors:  Alexander Piala; Diyar Mayi; Scott T Handy
Journal:  Tetrahedron       Date:  2011-06-10       Impact factor: 2.457

3.  Synthesis, antidepressant evaluation and docking studies of long-chain alkylnitroquipazines as serotonin transporter inhibitors.

Authors:  Mari Gabrielsen; Karol Wołosewicz; Anna Zawadzka; Jerzy Kossakowski; Gabriel Nowak; Małgorzata Wolak; Katarzyna Stachowicz; Agata Siwek; Aina W Ravna; Irina Kufareva; Lech Kozerski; Elżbieta Bednarek; Jerzy Sitkowski; Wojciech Bocian; Ruben Abagyan; Andrzej J Bojarski; Ingebrigt Sylte; Zdzisław Chilmonczyk
Journal:  Chem Biol Drug Des       Date:  2013-04-11       Impact factor: 2.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.